AKT1 and triple-negative breast carcinoma: Furthermore, we showed that CD74 is involved in the uptake of rTIMP‐1 by the triple negative breast cancer cell line, MDA‐MB‐231, and that this binding effects Akt signaling, which can lead to various cell responses.